ifestyle Intervention: Pilot Study for people with schizophrenia treated with either clozapine or another antipsychotic medicatio

Not Applicable

• Conditions: Schizophrenia; Overweight/obesity; Diet and Nutrition - Obesity; Mental Health - Schizophrenia

• Registration Number: ACTRN12619000723189
• Lead Sponsor: Hunter New England Mental Health Local health District

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-05-14
• Last Update Posted: 15 July 2019

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

•Age -18-65 years
•Taking clozapine for at least 18 weeks and are in maintenance phase or
•have been taking another antipsychotic medication for at least 6 months
•Are overweight or obese – BMI greater than 25
•Have access to transport – either by having their own car, or living in the area and near a bus stop, or have an NDIS support worker who can bring them

Exclusion Criteria

•Women who are pregnant
•Acutely unwell (psychotic) or an intellectual disability with severe cognitive impairment which would prevent them from participating in the behavioural program
•Are currently taking medications that may interfere with intervention ( for example metformin, diuretics, any other weight loss medication).
• Persons who are unable to read or write and understand the information statement, consent form, and self-report measures are ineligible. Informed consent must be obtained to be eligible for the study. As part of the dietary intervention, participants will learn about reading labels so that the right food products can be chosen. Basic level of reading and writing is required for this research.

Study & Design

• Study Type: Interventional
• Study Design: Not specified